unknown
Stage
1
Investors
About
InVera Medical develops the InVera Infusion Device, a single-use, minimally invasive catheter system for controlled delivery of physician-specified agents (such as sclerosants) to superficial and saphenous veins to treat chronic venous disease. The device has received FDA 510(k) clearance and CE Mark approval for commercial sale in the US and EU.
Explore InVera Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.